Campbell & Co Investment Adviser’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-11,692	Closed	-$394K	–	328
2014 Q4	$394K	Sell	11,692 -13,033	-53%	-$460K	0.24%	139
2014 Q3	$866K	Buy	+24,725	New	+$847K	0.44%	79

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Campbell & Co Investment Adviser's WX Position: Q1 2015 in Review

Campbell & Co Investment Adviser sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 11,692 shares — an estimated $394K sold.

Campbell & Co Investment Adviser first reported a position in WX in Q3 2014 and held it in 2 quarters. The position peaked at $866K in Q3 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Campbell & Co Investment Adviser reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Campbell & Co Investment Adviser sold 11,692 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $394K.
Campbell & Co Investment Adviser first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 2 quarters.
Campbell & Co Investment Adviser's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $866K in Q3 2014.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2015, filed 13 May 2015.